| Synonyms |
(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;BIBW 2992;Afatinib;(E)-N-(7-((S)-tetrahydrofuran-3-yloxy)-4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;(S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-2-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-;Afatinib ( BIBW-2992, BIBW 2992, Tovok®);Afatinib (BIBW2992);BIBW;BIBW-2992;BIBW2992 Afatinib;N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-Butenamide;(S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;2992;Biapenern;CL186815;L627;LJC10627;Omegacin;Tovok;BIBW2992;Tomtovok;BIBW2992 (Tovok);Afatinib free base;Afatinib, Free Base;C24H25ClFN5O3;(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide;41UD74L59M;N-[4-[(3-chl;Afatinib/BIBW2992 |
COA
